Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

VRP-034: A nephroprotective SMC complex of polymyxin B for Gram-negative infections

July 2, 2021

ETX-0462: a promising global Gram-negative antimicrobial agent

July 2, 2021

Oyster Point reports preclinical data on OC-01 and OC-02 against SARS-CoV-2 and variants

July 1, 2021

CureVac reports final data from phase IIb/III study of COVID-19 vaccine candidate CVnCoV

July 1, 2021

DksA1 inhibitors to suppress QS-mediated virulence of P. aeruginosa

July 1, 2021

Atea presents interim phase II data for AT-527 in hospitalized patients with COVID-19

July 1, 2021

Study suggests teicoplanin can improve outcomes in COVID pneumonia patients

July 1, 2021

New antifungals identified at Wigen Biomedicine Technology

July 1, 2021

FDA approves IND for phase I/II trial of ExoFlo for mild to moderate COVID-19

June 30, 2021

Altimmune discontinues AdCOVID development, updates T-COVID progress

June 30, 2021

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...